Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SentiMag/SiennaXP vs Standard of Care in Breast Cancer SLNB
NCT02336737Completed
- Sponsor
- Endomag
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Endomag. Primary endpoints: Number of Participants With Detected Lymph Nodes and Safety of SiennaXP and SentiMag® as Indicated by Adverse Events and Serious Adverse Events. Started Jan 2015; status: completed.
Beyond the preview
Go deeper on NCT02336737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336737.